Entrepreneurship for Scientists and Engineers
2. Compare the roles and goals of angel investors with those of venture capitalists.
Angel investors generally fill the gap between friendly money and venture capital up to
about $1 million. Angel investors are private individuals, usually ex-entrepreneurs, who
want to participate in the venture, so they are not passive investors, for the most part.
3. What are the unique issues related to biotech start-ups that make them different from
other high-tech ventures in the start-up stage?
One of the unique issues related to biotech start-ups is the extraordinarily long research and
development period, about 7 to 9 years for a new drug, up to 5 years for a medical device.
4. What role does the government play in the commercialization of new technology?
Most radically new technology begins as basic research funded by government agencies.
5. How can strategic partners be used to speed up the process of innovation and
commercialization?
Strategic partners can provide an infusion of capital or in-kind expertise and capability.
Although cash from strategic partners is generally in smaller amounts, it can be the cement